Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the Newspaper Advertisements published for the Un-Audited Financial Results for the quarter and half year ended September 30, 2020 in the newspapers, Financial Express (English Edition) and Jansatta (Hindi Edition) on 12th November, 2020. Genomic Valley Biotech Ltd - 539206 - Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2020
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Archies Limited ('Company') in its meeting held today approved the Un-Audited Financial Results (Standalone) for the Quarter and half year ended 30th September, 2020 of the Company as per Indian Accounting Standards (IND-AS) along with the Limited Review Report. Copy of the results along with the Limited Review Report of Statutory Auditors is attached herewith for your perusal. The above information will also be available on the Company's Website, www.genomicvalley.com . The meeting of the Board of Directors commenced on 11:45 A.M. and concluded at 04:30 P.M. Genomic Valley Biotech Ltd - 539206 - Submission Of Outcomes Of Board Meeting And Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2020
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Archies Limited ('Company') in its meeting held today approved the Un-Audited Financial Results (Standalone) for the Quarter and half year ended 30th September, 2020 of the Company as per Indian Accounting Standards (IND-AS) along with the Limited Review Report. Copy of the results along with the Limited Review Report of Statutory Auditors is attached herewith for your perusal. The above information will also be available on the Company's Website, www.genomicvalley.com . The meeting of the Board of Directors commenced on 11:45 A.M. and concluded at 04:30 P.M. Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the Newspaper Advertisements published for the Notice of Board Meeting to be held on 11th November, 2020, inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and half year ended 30th September, 2020, in the newspapers, Financial Express (English Edition) and Jansatta (Hindi Edition) on 30th October, 2020. Genomic Valley Biotech Ltd - 539206 - Closure of Trading Window
In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, the 11th November, 2020 at 11:45 A.M. inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and half year ended 30th September, 2020. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st October, 2020 till 48 hours of declaration of results i.e. 13th November, 2020 (both days inclusive). Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Intimation Regarding Holding Of Board Meeting On 11Th November, 2020 To Consider Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2020
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2020 ,inter alia, to consider and approve In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, the 11th November, 2020 at 11:45 A.M. inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and half year ended 30th September, 2020. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st October, 2020 till 48 hours of declaration of results i.e. 13th November, 2020 (both days inclusive). Genomic Valley Biotech Ltd - 539206 - Certificate Pursuant To Regulation 40 (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find enclosed herewith the certificate pursuant to Regulation 40 (10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half ended on 30th September, 2020. Genomic Valley Biotech Ltd - 539206 - Submission Of Compliance Certificate Pursuant To Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find enclosed herewith the Compliance Certificate pursuant to Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended on 30th September, 2020. Genomic Valley Biotech Ltd - 539206 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith the certificate pursuant to Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended on 30th September, 2020. Genomic Valley Biotech Ltd - 539206 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Yogesh AgrawalDesignation :- Managing Director / Whole Time Director